16. Schwab S, Aschoff A, Spranger M, et al: The value of intracranial pressure monitoring in acute hemispheric stroke. 3) . The brain damage at the time of injury, referred to as "primary injury," is considered to be the baseline situation. TBI management is mainly concerned with the prevention of "secondary injury" to avoid further ischemic or inflammatory damage to the brain. Internationally accepted guidelines for the resuscitation, monitoring, and treatment of TBI have been issued (4). Most of these guidelines are based on level II or III evidence, indicating a general lack of good randomized controlled trials in this area.
Prognostic scores are statistical models that describe the relationship between certain patient characteristics and outcome. Early prognostic models in TBI have never been widely used because they were developed on small and often incomplete databases, were not externally validated, and impractical to use (5). Based on the large International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) (6) and Corticosteroid Randomization After Significant Head Injury (CRASH) (7) databases, two models were developed using multivariable logistic regression. These models were validated internally as well as on each other's databases (8). Models have been developed to predict death at 2 wks (CRASH) and 6 months (IMPACT), and unfavorable outcome at 6 months (defined as Glasgow Outcome Score 1-3). Although they have been developed in different data sets, the models are very similar and use almost the same variables. Age, pupil size, and total Glasgow Coma Score (GCS) or GCS motor score are predictors in both the IMPACT core and the CRASH basic model, with extracranial injury as an additional predictor in the latter. Both models come with extended versions: the CRASH-CT model includes scoring the presence or absence of five possible computer tomography (CT) findings; the IMPACT-core+CT model includes the Marshall CT classification and the presence of prehospital hypoxia or hypotension; the IMPACT-core+CT+lab model adds blood glucose and hemoglobin. The predictive performance of the extended versions is only a little better than the core and basic models.
In this issue of Critical Care Medicine, Roozenbeek and colleagues (9) present an additional external validation of both models in five new data sets. External validation is the best method to demonstrate generalizability of a predictive model. The study has several strengths, the robust statistical techniques being one of them. The four smallest data sets, between 385 and 856 patients, are taken from three randomized controlled trials and one observational study. The largest data set, 6,874 patients, was selected from the Trauma Audit and Registry Network (TARN). The discriminative power of the models in the different data sets varies, with area under the receiveroperator characteristic curves between 0.650 and 0.848 for mortality and between 0.656 and 0.758 for unfavorable outcome. The area under the receiveroperator characteristic curves of IMPACT and CRASH have not been compared statistically, but the models appear to perform equally. The higher area under the receiver-operator characteristic curves in the TARN and apolipoprotein E data sets are attributed to their observational nonrandomized nature, and thus a more heterogeneous patient population. The discrepancies in calibration plots could be largely explained by the different outcome distribution between IMPACT and CRASH development cohorts and the five validation data sets. Because of missing data and differences in registered parameters, small adaptations had to be made to the CRASH and IMPACT models. This is a weakness of the present study, rightfully acknowledged by the authors. In the modified CRASH model, the GCS total was replaced by the GCS motor score, as in the IMPACT model. In the TARN data set, an Abbreviated Injury Score-derived Marshall CT classification had to be used for the IMPACT model, which is acceptable but implies making certain assumptions (10). The automatic imputation of pupil reactivity in the TARN database is highly problematic: any method for missing data imputation has the potential of introducing bias because assumptions are made with regard to the distribution. When 90% of one of three or four predictors is missing, results should be interpreted with caution. One should be very cautious when using "predictive" models such as IMPACT and CRASH for "forecasting" in individual patients. Outcome predictions, when presented to clinicians by a computer, have been shown to reduce the use of certain therapies in TBI patients with a predicted poorer outcome (11). This way, predictions bear the risk of becoming self-fulfilling prophecies. The unequal performance in different data sets of both models demonstrates that the performance of a good and well-validated predictive model will not necessarily stand in a new data set. A specific clinical context or differences in case-mix may require recalibrating the models in this new context to obtain the same predictive accuracy as the original models. Models built for prediction in a certain broad population should not be used for predictions in individuals of a different particular population. On top of that, the outcome of individual patients is highly influenced by secondary injuries such as episodes of intracranial hypertension in the hours and days after TBI (12), not assessed by both models.
Apart from that, CRASH and IMPACT initiatives remain true milestones for future scientific work on TBI. They are of immense value for the purpose of case-mix adjustment for randomized controlled trials, registries, and quality assessment. They are robust over different clinical settings and geographical regions, as confirmed by Roozenbeek and colleagues (9). It is actually quite exciting that the baseline risk of a TBI patient can be assessed using such a sparse model, with only three or four predictors. However, the separate value of having two models is debatable (13), especially since they perform similarly, and use approximately the same predictors: age, GCS, and pupil reaction to light. In the combined IMPACT, CRASH, and TARN data sets (39,274 patients), the same authors have demonstrated that major extracranial injury used by the CRASH model is a significant baseline risk factor, although its strength as predictor is smaller when brain injury is more severe and depends on the time of assessment (14). It is our opinion that future efforts should focus on combining data sets to develop and validate a single predictive model.
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